TCNL joins forces with U.S. Army for Research

Signing Ceremony, Fort Detrick, Maryland

Left to right: Col. Lopez-Duke, Col. Miller, Col. Dallas Hack (Director of MRMC), Montel Williams, Phil Deschamps (CEO, NeuroHabilitation, Corp.), Mitchell Tyler, Kurt Kaczmarek, Yuri Danilov


On February 8, 2013, the U.S. Army Medical Research and Materiel Command (USAMRMC) entered into a Cooperative Research and Development Agreement with NeuroHabilitation Corporation (NHC), a company formed by the TCNL co-directors in collaboration with TV personality Montel Williams, medical device specialist Jonathan Sackier, and Medimedia Health CEO Phil Deschamps. The new Agreement allows the Army to work with NHC and TCNL to further develop and evaluate the PoNS™ device for use with soldiers who have experienced blast-related traumatic brain injuries.

“This exciting agreement leverages a unique private-public partnership,” said Colonel Dallas Hack, director of the USAMRMC Combat Casualty Care Research Program. “By collaborating with University of Wisconsin-Madison and NeuroHabilitation Corporation, we maximize our resources to explore a potential real-world treatment for injured service members and civilians with a variety of health conditions.”

Link to related Army press release

More pictures from the signing ceremony can be found here (this link will take you to a Facebook page).



February 2018

Featured Video